ActivePassive International Equity ETF (APIE)

APIE is an actively-managed fund that blends active and passive investment strategies to optimize costs, tracking and potential return over the S&P Classic ADR Composite Index, the Fund’s benchmark index. The Fund also employs a strategic beta strategy for a portion of the Fund’s investment portfolio. The ratio of the Fund’s investment portfolio that is actively versus passively managed is determined by a variety of factors, including Envestnet's proprietary methodologies and academic research on factor investing. 

APIE will invest at least 80% of its net assets in equity securities of non-U.S. companies with varying market capitalizations. The Fund’s investment in equity securities may include common stock and preferred stock of companies that are either domiciled or have their primary operations outside the United States. The Fund may invest in companies located in non-U.S. developed markets and in companies located in emerging markets. The Fund may also invest in both American depositary receipts (“ADRs”) and in securities of non-U.S. companies that are denominated in foreign currencies. The Fund carries an expense ratio of 0.45%.

Fund Data & Pricing Data as of 11/19/2024
Net Assets as of 11/19/2024 $791m
NAV $28.74
Shares Outstanding 27,525,000
Premium/discount Percentage 0.29%
Closing Price $28.82
Median 30 Day Spread 0.34%

Median 30 Day Spread is a calculation of Fund's median bid-ask spread, expressed as a percentage rounded to the nearest hundredth, computed by: identifying the Fund's national best bid and national best offer as of the end of each 10 second interval during each trading day of the last 30 calendar days; dividing the difference between each such bid and offer by the midpoint of the national best bid and national best offer; and identifying the median of those values.

Fund Details
Inception Date 05/03/2023
Ticker APIE
Primary Exchange NYSE
CUSIP 89834G737
IOPV Symbol APIE.IV
NAV Symbol APIE.NV
Expense Ratio 0.45%

* As of 05/03/2023

Performance Quarter end returns as of 8/31/2024
  Avg. Annualized  
  3 Month 6 Month 9 Month 1 Year Since Inception
Fund NAV 3.68% 9.15% 17.31% 18.90% 15.69%
Market Price 3.93% 9.05% 17.83% 18.93% 15.75%
S&P Classic ADR Composite Index (USD) NTR 3.78% 9.90% 17.47% 18.73% 14.66%

Expense ratio: 0.45%

Inception Date:  05/03/2023

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. Performance current to the most recent month-end can be obtained by calling 1-800-617-0004.

Short term performance, in particular, is not a good indication of the fund's future performance, and an investment should not be made based solely on returns.

Periods of less than 1-Year are unannualized

Market Price: The current price at which shares are bought and sold. Market returns are based upon the last trade price.

NAV: The dollar value of a single share, based on the value of the underlying assets of the fund minus its liabilities, divided by the number of shares outstanding. Calculated at the end of each business day.

Distribution Detail
Ex-Date Record Date 1 Year Payable Date
12/26/2023 12/27/2023 12/28/2023
TOP 10 HOLDINGS
% Of Net Assets Name Ticker CUSIP Shares Held Market Value
5.96% Taiwan Semiconductor Manufacturing Co Ltd TSM 874039100 249,456 46,987,532.16
2.38% Tencent Holdings Ltd TCEHY 88032Q109 359,053 18,817,967.73
2.01% SAP SE SAP 803054204 67,388 15,837,527.76
1.51% RELX PLC RELX 759530108 264,793 11,944,812.23
1.45% Novo Nordisk A/S NVO 670100205 109,035 11,478,114.45
1.33% Novartis AG NVS 66987V109 101,419 10,455,284.71
1.29% Roche Holding AG RHHBY 771195104 290,155 10,193,145.15
1.28% Unilever PLC UL 904767704 176,119 10,135,648.45
1.23% AstraZeneca PLC AZN 046353108 153,864 9,724,204.80
1.21% HSBC Holdings PLC HSBC 404280406 207,012 9,570,164.76

Data as of 11/21/2024. Holdings are subject to change.